Reference health
Calcium Channel blockers are associated with reduced risk of Parkinson's disease in patients with hypertension: A population-based retrospective cohort study
32/32 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 32 checked references that resolve
resolves10.1016/S1474-4422(16)30230-7
The epidemiology of Parkinson's disease: risk factors and prevention
resolves10.1159/000113678
Basic Research on Dopamine in Parkinson’s Disease and the Discovery of the Nigrostriatal Dopamine Pathway: The View of an Eyewitness
resolves10.1016/j.neuroscience.2011.08.045
The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease
resolves10.1111/j.1476-5381.1994.tb17068.x
Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones
resolves10.1074/jbc.R112.410530
Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease
resolves10.1038/nature09536
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
resolves10.1146/annurev-pharmtox-010818-021214
The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease
resolves10.1038/nn.3209
Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease
resolves10.1523/JNEUROSCI.21-16-05944.2001
Neuronal Ca<sub>V</sub>1.3α<sub>1</sub>L-Type Channels Activate at Relatively Hyperpolarized Membrane Potentials and Are Incompletely Inhibited by Dihydropyridines
resolves10.1212/01.wnl.0000303818.38960.44
Use of antihypertensives and the risk of Parkinson disease
resolves10.1016/j.parkreldis.2006.08.011
Calcium channel blockers and β-blockers in relation to Parkinson's disease
resolves10.1159/000235641
Antihypertensive Agents and Risk of Parkinson’s Disease, Essential Tremor and Dementia: A Population-Based Prospective Study (NEDICES)
resolves10.1161/HYPERTENSIONAHA.111.171249
Association of Blood Pressure and Hypertension With the Risk of Parkinson Disease
resolves10.3389/fneur.2018.00162
Hypertension and Diagnosis of Parkinson’s Disease: A Meta-Analysis of Cohort Studies
resolves10.1007/s10072-020-04277-w
Association of orthostatic hypotension with Parkinson’s disease: a meta-analysis
resolves10.1002/pds.819
How well do patients report noncompliance with antihypertensive medications?: a comparison of self‐report versus filled prescriptions
resolves10.1002/mds.23828
Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
resolves10.1016/bs.irn.2019.10.010
Secondary parkinsonism due to drugs, vascular lesions, tumors, trauma, and other insults
resolves10.1016/S1353-8020(98)00032-7
Calcium channel blocker-induced parkinsonism: clinical features and comparisons with Parkinson's disease
resolves10.1136/pgmj.2008.073312
Drug induced parkinsonism: a common cause of parkinsonism in older people
resolves10.1126/science.aam9080
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
resolves10.1016/j.neuint.2016.07.003
Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
resolves10.1093/brain/114.5.2283
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
The 1 reference without a DOI — listed, not checked
no DOI — not checkedAntihypertensive agents and risk of Parkinson's disease: a nationwide cohort study
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.jns.2021.117412"><img src="https://citestamp.com/citestamped/10.1016/j.jns.2021.117412/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.jns.2021.117412)